Savara Pharmaceuticals
SVRA
#6301
Rank
HK$4.82 B
Marketcap
HK$29.29
Share price
4.72%
Change (1 day)
8.59%
Change (1 year)

Earnings for Savara Pharmaceuticals (SVRA)

Earnings in 2024 (TTM): -HK$0.59 B

According to Savara Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -HK$0.59 B. In 2023 the company made an earning of -HK$0.43 B a decrease over its 2022 earnings that were of -HK$0.3 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara Pharmaceuticals from 2002 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -HK$0.59 B38.5%
2023 -HK$0.43 B43.38%
2022 -HK$0.3 B-11.31%
2021 -HK$0.34 B-13.3%
2020 -HK$0.39 B-36.53%
2019 -HK$0.61 B13.76%
2018 -HK$0.54 B105.54%
2017 -HK$0.26 B34.11%
2016 -HK$0.2 B-37.43%
2015 -HK$0.31 B38.81%
2014 -HK$0.23 B33.62%
2013 -HK$0.17 B38.49%
2012 -HK$0.13 B24.59%
2011 -HK$96.74 M-36.5%
2010 -HK$0.16 B-3.14%
2009 -HK$0.16 B-23.28%
2008 -HK$0.21 B8.52%
2007 -HK$0.19 B-34.14%
2006 -HK$0.29 B184.43%
2005 -HK$0.11 B90.75%
2004 -HK$52.87 M190.35%
2003 -HK$18.21 M11.64%
2002 -HK$16.32 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-HK$0.15 B-75.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$1.91 B 224.94%๐Ÿ‡บ๐Ÿ‡ธ USA